This compound is a pharmaceutical active ingredient belonging to the statin class, functioning as an HMG-CoA reductase inhibitor. It is a synthetic organic molecule characterized by multiple aromatic rings, an alcohol group, and an ester moiety, making it suitable for use in pharmaceutical manufacturing and research.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 375846-25-6
(RS)-furaltadone hydrochloride
pharmaceutical raw material
Maraviroc
pharmaceutical raw material
Nafenopin
pharmaceutical raw material
Ifosfamide
pharmaceutical raw material
Fluvastatin methyl ester
pharmaceutical intermediate
(3R,5S)-fluvastatin sodium
pharmaceutical raw material
3-Methyl(E)-7-[3-(4-fluorophenyl)-1-methylethyl-indol-2-yl]-3-hydroxy-5-oxohept-6-enoate
pharmaceutical intermediate
(E)-3-[3'-(4''-Fluorophenyl)-1'-(1''-methylethyl)-1H-indol-2''-yl]-2-propnal
pharmaceutical intermediate
tert-butyl (E)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-5-hydroxy-3-oxohept-6-enoate
CHEYRYWZYKYUHU-CCEZHUSRSA-N
CC(C)N1C2=CC=CC=C2C(=C1/C=C/C(CC(=O)CC(=O)OC(C)(C)C)O)C3=CC=C(C=C3)F